Functional impairment in people with schizophrenia: Focus on employability and eligibility for disability compensation

BACKGROUND The Social Security Administration (SSA) is considering whether schizophrenia may warrant inclusion in their new "Compassionate Allowances" process, which aims to identify diseases and other medical conditions that invariably quality for Social Security disability benefits and require no more than minimal objective medical information. This paper summarizes evidence on the empirical association between schizophrenia and vocational disability. A companion paper examines the reliability and validity of schizophrenia diagnosis which is critically relevant for granting a long-term disability on the basis of current diagnosis. METHODS This is a selective literature review and synthesis, based on a work plan developed in a meeting of experts convened by the National Institute of Mental Health and the SSA. This review of the prevalence of disability is focused on the criteria for receipt of disability compensation for psychotic disorders currently employed by the SSA. RESULTS Disability in multiple functional domains is detected in nearly every person with schizophrenia. Clinical remission is much more common than functional recovery, but most patients experience occasional relapses even with treatment adherence, and remissions do not predict functional recovery. Under SSA's current disability determination process, approximately 80% of SSDI/SSI applications in SSA's diagnostic category of "Schizophrenia/Paranoid Functional Disorders" are allowed, compared to around half of SSDI/SSI applications overall. Moreover, the allowance rate is even higher among applicants with schizophrenia. Many unsuccessful applicants are not denied, but rather simply are unable to manage the process of appeal after initial denials. DISCUSSION Research evidence suggests that disability applicants with a valid diagnosis of schizophrenia have significant impairment across multiple dimensions of functioning, and will typically remain impaired for the duration of normal working ages or until new interventions are developed.

[1]  R. Gur,et al.  Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. , 1994, Archives of general psychiatry.

[2]  J. Lieberman,et al.  Psychobiologic Correlates of Treatment Response in Schizophrenia , 1996, Neuropsychopharmacology.

[3]  Michael F. Green,et al.  Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial , 2006, Neuropsychopharmacology.

[4]  Philip D. Harvey,et al.  Predicting Schizophrenia Patients’ Real-World Behavior with Specific Neuropsychological and Functional Capacity Measures , 2008, Biological Psychiatry.

[5]  Janet B W Williams Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[6]  L. Dixon,et al.  Cognitive correlates of job tenure among patients with severe mental illness. , 2002, The American journal of psychiatry.

[7]  J. Lieberman,et al.  Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. , 1999, The American journal of psychiatry.

[8]  Philip D. Harvey,et al.  Relationship of the Brief UCSD Performance-based Skills Assessment (UPSA-B) to multiple indicators of functioning in people with schizophrenia and bipolar disorder. , 2010, Bipolar disorders.

[9]  Philip D. Harvey,et al.  Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. , 2001, The American journal of psychiatry.

[10]  P. Weiden,et al.  Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. , 2004, Psychiatric services.

[11]  N. Andreasen,et al.  Dependence on public financial support early in the course of schizophrenia. , 1997, Psychiatric services.

[12]  J. Haro,et al.  Worldwide‐Schizophrenia Outpatient Health Outcomes (W‐SOHO): baseline characteristics of pan‐regional observational data from more than 17,000 patients * , 2009, International journal of clinical practice.

[13]  Jane S. Paulsen,et al.  Is it possible to be schizophrenic yet neuropsychologically normal? , 1997, Neuropsychology.

[14]  B. Mausbach,et al.  Development of a brief scale of everyday functioning in persons with serious mental illness. , 2006, Schizophrenia bulletin.

[15]  M. Tohen,et al.  One hundred years of schizophrenia: a meta-analysis of the outcome literature. , 1994 .

[16]  T. Wykes,et al.  The Measurement of Social Behaviour in Psychiatric Patients: An Assessment of the Reliability and Validity of the SBS Schedule , 1986, British Journal of Psychiatry.

[17]  J. Lieberman,et al.  Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III , 2005, Schizophrenia Research.

[18]  J. Os,et al.  Remission criteria for schizophrenia: Evaluation in a large naturalistic cohort , 2007, Schizophrenia Research.

[19]  S. Faraone,et al.  Neurocognition in first-episode schizophrenia: a meta-analytic review. , 2009, Neuropsychology.

[20]  Philip D. Harvey,et al.  Clinical, cognitive and functional characteristics of long-stay patients with schizophrenia: a comparison of VA and state hospital patients , 2000, Schizophrenia Research.

[21]  Emil Kraepelin,et al.  Dementia praecox and paraphrenia , 2002 .

[22]  J. Gold,et al.  The role of negative symptoms and cognitive dysfunction in schizophrenia outcome , 1998, International clinical psychopharmacology.

[23]  T. Patterson,et al.  Social skills performance assessment among older patients with schizophrenia , 2001, Schizophrenia Research.

[24]  R. Drake,et al.  Job Terminations Among Persons with Severe Mental Illness Participating in Supported Employment , 1998, Community Mental Health Journal.

[25]  M. Bell,et al.  INITIAL AND FINAL WORK PERFORMANCE IN SCHIZOPHRENIA:: COGNITIVE AND SYMPTOM PREDICTORS , 2003, The Journal of nervous and mental disease.

[26]  J. Gold,et al.  No, it is not possible to be schizophrenic yet neuropsychologically normal. , 2005, Neuropsychology.

[27]  J. Lieberman,et al.  Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. , 1999, Archives of general psychiatry.

[28]  P. Weiden,et al.  The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. , 2009, The Journal of clinical psychiatry.

[29]  G. Oster,et al.  Risperidone versus Conventional Antipsychotics for Schizophrenia and Schizoaffective Disorder , 2004, Clinical drug investigation.

[30]  Philip D. Harvey,et al.  Functional implications of neuropsychological normality and symptom remission in older outpatients diagnosed with schizophrenia: A cross-sectional study , 2008, Journal of the International Neuropsychological Society.

[31]  Krzysztof Narkiewicz,et al.  The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy: a randomized controlled trial , 2010, Journal of hypertension.

[32]  Philip D. Harvey,et al.  Performance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and Sweden. , 2009, The American journal of psychiatry.

[33]  J. Lieberman,et al.  Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline , 2006, Schizophrenia Research.

[34]  Philip D. Harvey,et al.  Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. , 2009, Schizophrenia bulletin.

[35]  T. Patterson,et al.  SElf-reported social functioning among older patients with schizophrenia , 1997, Schizophrenia Research.

[36]  D. Braff,et al.  Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? , 2000, Schizophrenia bulletin.

[37]  T. Patterson,et al.  Heterogeneity in functional status among older outpatients with schizophrenia: employment history, living situation, and driving , 2002, Schizophrenia Research.

[38]  N C Andreasen,et al.  Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. , 1998, The American journal of psychiatry.

[39]  J. Gold,et al.  General and specific cognitive deficits in schizophrenia , 2004, Biological Psychiatry.

[40]  Philip D. Harvey,et al.  Determinants of everyday outcomes in schizophrenia: The influences of cognitive impairment, functional capacity, and symptoms , 2009, Schizophrenia Research.

[41]  The long-term impact of employment on mental health service use and costs for persons with severe mental illness. , 2009 .

[42]  Philip D. Harvey,et al.  Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder. , 2010, The American journal of psychiatry.

[43]  B. Mausbach,et al.  Functional Adaptation Skills Training (FAST): A randomized trial of a psychosocial intervention for middle-aged and older patients with chronic psychotic disorders , 2006, Schizophrenia Research.

[44]  P. Barreira,et al.  Long-stay patients in state psychiatric hospitals at the end of the 20th century. , 2001, Psychiatric services.

[45]  T. McGlashan,et al.  Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course. , 1991, Archives of general psychiatry.

[46]  Tyrone D. Cannon,et al.  Dorsolateral prefrontal cortex activity during maintenance and manipulation of information in working memory in patients with schizophrenia. , 2005, Archives of general psychiatry.

[47]  Robert M Bilder,et al.  Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. , 2004, The American journal of psychiatry.

[48]  Michael F. Green,et al.  What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.

[49]  G Honigfeld,et al.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. , 1988, Archives of general psychiatry.

[50]  B. Druss,et al.  Quality of medical care and excess mortality in older patients with mental disorders. , 2001, Archives of general psychiatry.

[51]  Konstantine K. Zakzanis,et al.  Neurocognitive Deficit in Schizophrenia: A Quantitative Review of the Evidence , 1998 .

[52]  M. Davidson,et al.  Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode , 2003, Schizophrenia Research.

[53]  Philip D. Harvey,et al.  Neuropsychological differences between first-admission schizophrenia and psychotic affective disorders. , 2000, The American journal of psychiatry.

[54]  Philip D. Harvey,et al.  The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone , 2007, Schizophrenia Research.

[55]  W. Carpenter The deficit syndrome. , 1994, The American journal of psychiatry.

[56]  Philip D. Harvey,et al.  Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem. , 2009, Schizophrenia bulletin.

[57]  R. Gur,et al.  Neuropsychological function in schizophrenia. Selective impairment in memory and learning. , 1991, Archives of general psychiatry.

[58]  M. Toprac,et al.  Results of a multisite randomized trial of supported employment interventions for individuals with severe mental illness. , 2005, Archives of general psychiatry.

[59]  Philip D. Harvey,et al.  Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept? , 2009, Schizophrenia bulletin.

[60]  S. Faraone,et al.  The paradox of normal neuropsychological function in schizophrenia. , 2000, Journal of abnormal psychology.

[61]  Christian R. Dolder,et al.  Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia , 2003, Schizophrenia Research.

[62]  Larry J Seidman,et al.  Premorbid IQ in schizophrenia: a meta-analytic review. , 2008, The American journal of psychiatry.

[63]  W T Carpenter,et al.  Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. , 1992, Archives of general psychiatry.

[64]  D. Pickar,et al.  National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. , 1991, Archives of general psychiatry.

[65]  P. Meyer,et al.  Cognitive and clinical predictors of success in vocational rehabilitation in schizophrenia , 2004, Schizophrenia Research.

[66]  R. Buchanan,et al.  A separate disease within the syndrome of schizophrenia. , 2001, Archives of general psychiatry.

[67]  J. Lieberman,et al.  Relationship of cognition and psychopathology to functional impairment in schizophrenia. , 2008, The American journal of psychiatry.

[68]  Philip D. Harvey,et al.  Differential preservation of cognitive functions in geriatric patients with lifelong chronic schizophrenia: less impairment in reading compared with other skill areas , 2000, Biological Psychiatry.

[69]  D. Jeste,et al.  Stability and course of neuropsychological deficits in schizophrenia. , 2001, Archives of general psychiatry.

[70]  Marvin Swartz,et al.  Barriers to employment for people with schizophrenia. , 2006, The American journal of psychiatry.

[71]  R. Conley,et al.  Rehospitalization Risk with Second-Generation and Depot Antipsychotics , 2003, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[72]  J. Gold,et al.  Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. , 2007, Archives of general psychiatry.